A detailed history of Prio Wealth Limited Partnership transactions in Amgen Inc stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 25,525 shares of AMGN stock, worth $8.49 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares
25,525
Previous 26,824 4.84%
Holding current value
$8.49 Million
Previous $7.63 Million 4.58%
% of portfolio
0.24%
Previous 0.22%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Sep 10, 2024

SELL
$262.75 - $319.31 $341,312 - $414,783
-1,299 Reduced 4.84%
25,525 $7.98 Million
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $427,234 - $515,725
1,589 Added 6.3%
26,824 $7.63 Million
Q4 2023

Jan 22, 2024

SELL
$255.7 - $288.46 $19,177 - $21,634
-75 Reduced 0.3%
25,235 $7.27 Million
Q3 2023

Oct 31, 2023

SELL
$218.65 - $271.46 $35,202 - $43,705
-161 Reduced 0.63%
25,310 $6.8 Million
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $3,214 - $3,800
-15 Reduced 0.06%
25,471 $5.66 Million
Q1 2023

May 12, 2023

SELL
$225.79 - $275.2 $142,247 - $173,376
-630 Reduced 2.41%
25,486 $6.16 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $203,378 - $258,416
-888 Reduced 3.29%
26,116 $0
Q3 2022

Feb 27, 2023

SELL
$224.46 - $253.15 $128,391 - $144,801
-572 Reduced 2.17%
25,820 $5.82 Million
Q2 2022

Feb 27, 2023

BUY
$230.71 - $256.74 $63,675 - $70,860
276 Added 1.06%
26,392 $6.42 Million
Q1 2022

Feb 21, 2023

BUY
$219.27 - $242.57 $23,681 - $26,197
108 Added 0.41%
26,224 $6.34 Million
Q4 2021

Feb 17, 2022

SELL
$198.88 - $227.6 $99,042 - $113,344
-498 Reduced 1.81%
27,004 $6.08 Million
Q3 2021

Nov 12, 2021

SELL
$212.27 - $248.7 $379,114 - $444,178
-1,786 Reduced 6.1%
27,502 $5.85 Million
Q2 2021

Aug 16, 2021

SELL
$233.58 - $259.14 $757,733 - $840,650
-3,244 Reduced 9.97%
29,288 $7.14 Million
Q1 2021

May 06, 2021

SELL
$221.91 - $258.6 $1 Million - $1.17 Million
-4,513 Reduced 12.18%
32,532 $8.09 Million
Q4 2020

Feb 04, 2021

SELL
$216.38 - $257.67 $134,804 - $160,528
-623 Reduced 1.65%
37,045 $8.52 Million
Q3 2020

Nov 16, 2020

BUY
$234.65 - $260.95 $168,478 - $187,362
718 Added 1.94%
37,668 $9.57 Million
Q2 2020

Aug 11, 2020

SELL
$197.81 - $242.74 $64,288 - $78,890
-325 Reduced 0.87%
36,950 $8.72 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $1.13 Million - $1.5 Million
-6,216 Reduced 14.29%
37,275 $7.56 Million
Q4 2019

Feb 10, 2020

SELL
$189.21 - $243.2 $354,768 - $456,000
-1,875 Reduced 4.13%
43,491 $10.5 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $4,352 - $5,215
-25 Reduced 0.06%
45,366 $8.78 Million
Q2 2019

Jul 18, 2019

SELL
$166.7 - $195.41 $374,074 - $438,500
-2,244 Reduced 4.71%
45,391 $8.36 Million
Q1 2019

May 03, 2019

SELL
$180.87 - $203.88 $108,883 - $122,735
-602 Reduced 1.25%
47,635 $9.05 Million
Q4 2018

Feb 06, 2019

SELL
$178.4 - $208.25 $528,420 - $616,836
-2,962 Reduced 5.79%
48,237 $9.39 Million
Q3 2018

Nov 07, 2018

BUY
$185.29 - $208.89 $240,691 - $271,348
1,299 Added 2.6%
51,199 $10.6 Million
Q2 2018

Aug 06, 2018

SELL
$166.05 - $186.51 $168,706 - $189,494
-1,016 Reduced 2.0%
49,900 $9.21 Million
Q1 2018

Apr 17, 2018

BUY
$169.43 - $198.0 $8.63 Million - $10.1 Million
50,916 New
50,916 $8.68 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.